These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30902795)

  • 41. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
    Huang WT; Chong IW; Chen HL; Li CY; Hsieh CC; Kuo HF; Chang CY; Chen YH; Liu YP; Lu CY; Liu YR; Liu PL
    Cancer Lett; 2019 Feb; 442():287-298. PubMed ID: 30439539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced antitumor activity of 3-bromopyruvate in combination with rapamycin in vivo and in vitro.
    Zhang Q; Pan J; Lubet RA; Komas SM; Kalyanaraman B; Wang Y; You M
    Cancer Prev Res (Phila); 2015 Apr; 8(4):318-26. PubMed ID: 25644152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.
    Gao J; Qiu X; Xi G; Liu H; Zhang F; Lv T; Song Y
    Oncol Rep; 2018 Oct; 40(4):1971-1984. PubMed ID: 30106450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
    Jin JJ; Liu YH; Si JM; Ni R; Wang J
    Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Availability of the key metabolic substrates dictates the respiratory response of cancer cells to the mitochondrial uncoupling.
    Zhdanov AV; Waters AH; Golubeva AV; Dmitriev RI; Papkovsky DB
    Biochim Biophys Acta; 2014 Jan; 1837(1):51-62. PubMed ID: 23891695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function.
    Jia X; Gu Z; Chen W; Jiao J
    Fundam Clin Pharmacol; 2016 Aug; 30(4):297-306. PubMed ID: 27009695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of the integrin signaling adaptor protein NEDD9 on prognosis and metastatic behavior of human lung cancer.
    Kondo S; Iwata S; Yamada T; Inoue Y; Ichihara H; Kichikawa Y; Katayose T; Souta-Kuribara A; Yamazaki H; Hosono O; Kawasaki H; Tanaka H; Hayashi Y; Sakamoto M; Kamiya K; Dang NH; Morimoto C
    Clin Cancer Res; 2012 Nov; 18(22):6326-38. PubMed ID: 23037767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer.
    Chen X; Yu C; Gao J; Zhu H; Cui B; Zhang T; Zhou Y; Liu Q; He H; Xiao R; Huang R; Xie H; Gao D; Zhou H
    Theranostics; 2018; 8(9):2348-2360. PubMed ID: 29721084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 53. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oroxylin A sensitizes non-small cell lung cancer cells to anoikis via glucose-deprivation-like mechanisms: c-Src and hexokinase II.
    Wei L; Dai Q; Zhou Y; Zou M; Li Z; Lu N; Guo Q
    Biochim Biophys Acta; 2013 Jun; 1830(6):3835-45. PubMed ID: 23500080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation.
    Wang X; Chen Z
    Int J Mol Med; 2015 Mar; 35(3):839-46. PubMed ID: 25604748
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-485-5p suppresses growth and metastasis in non-small cell lung cancer cells by targeting IGF2BP2.
    Huang RS; Zheng YL; Li C; Ding C; Xu C; Zhao J
    Life Sci; 2018 Apr; 199():104-111. PubMed ID: 29510198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
    Long D; Yu T; Chen X; Liao Y; Lin X
    Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glucose metabolism provide distinct prosurvival benefits to non-small cell lung carcinomas.
    Wu R; Galan-Acosta L; Norberg E
    Biochem Biophys Res Commun; 2015 May; 460(3):572-7. PubMed ID: 25819414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K/AKT signal pathway by targeting MALAT-1.
    Zhang X; He X; Liu Y; Zhang H; Chen H; Guo S; Liang Y
    Biomed Pharmacother; 2017 Sep; 93():1065-1073. PubMed ID: 28738500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.